Min-Ki Seong

8PUBLICATIONS
51CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 04, 2026
α-Viniferin Induces Intrinsic Apoptosis in Triple-Negative Breast Cancer Cells and Synergizes With SB203580 Independently of p38 Mitogen-Activated Protein Kinase.

|May 28, 2025
Trends and Perspectives in Oncoplastic Breast Surgery: Findings From a Web-Based Survey With the Korean Breast Cancer Society.

Jeeyeon Lee, Byeongju Kang, Ho Yong Park

|Jul 13, 2023
Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?

Juhyeon Lee, Chan Sub Park, Jeong Hun Oh

|Jul 13, 2023
Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy.

Hyung Jin Kim, Juhyeon Lee, In-Chul Park

|Jan 05, 2023
Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry.

Hannah Lois Kangleon-Tan, Jongmin Sim, Ji Young You

|Oct 31, 2022
The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer.

Ji Yea Kim, Chan Sub Park, Se-Kyeong Jang

Pageof 2

Frequent Collaborators

6 joint publications

Hyun-Ah Kim

5 joint publications

Chan Sub Park

5 joint publications

In-Chul Park

5 joint publications

Woo Chul Noh